UnknownNot Applicable

Clinical Significance of circMETTL9 Gene in Traumatic Brain Injury

China150 participantsStarted 2022-08-04

Plain-language summary

Objective: The relevance of circMETTL9 to the degree of injury, disturbance of consciousness, cognitive function and prognosis in patients with moderate to severe traumatic brain injury (TBI) remains unknown. The purpose of this study was to investigate the effect of circMETTL9 on the degree of injury, disturbance of consciousness, cognitive function and prognosis after TBI.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age from 18 to 80 years old, gender is not limited;
✓. Have a clear history of TBI and be diagnosed by head CT, and it is the first episode;
✓. Glasgow Coma Scale (GCS) score less than or equal to 12;
✓. The condition is relatively stable, and there is no serious chronic disease;
✓. Obtain informed consent from patients and (or) their families.

What they're measuring

The sensitivity and specificity of circMETTL9 in TBI patients were analyzed.

Timeframe: 2022-01-2023-12

Trial details

NCT IDNCT05484921

SponsorAffiliated Hospital of Nantong University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-30

Contact for this trial

liu su, PhD

13814701181 327202278@qq.com

View on ClinicalTrials.gov More TBI (Traumatic Brain Injury) trials